ENTITY
Sun Pharma

Sun Pharma (SUNP IN)

353
Analysis
Health Care • India
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs). It offers a wide range of products across chronic and acute therapies, including generics, branded generics, and specialty products. The company was founded in 1983 and is headquartered in Mumbai, India.
more
bullish•Sony Financial Group
•12 Jan 2018 09:51

BBSP Equity Asia Weekly Research 10th January 2018

Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAP• HSCEI/MXAP ratio is moving in a range pattern. Therefore downgrade...

Logo
472 Views
Share
•08 May 2026 19:20

How Torrent Won the Generic Semaglutide Race?

​Torrent Pharmaceuticals dominates India's generic semaglutide market, capitalizing on early share in a growing anti-obesity market set to reach...

Logo
180 Views
Share
•28 Dec 2017 23:24

Emerging Markets: Outlook and Recommendations

Today's report provides a synopsis of the technical state of emerging markets, along with actionable countries and a wide variety of bottom-up...

Logo
365 Views
Share
•30 Nov 2017 02:29

Emerging Markets: Technical Strategy & Reccommendations

Today’s report provides a top-down synopsis of the technical condition of emerging markets across the globe, and includes a wide variety of...

Logo
1.2k Views
Share
bearish•Orkla India Ltd.
•29 Apr 2026 10:40

Aequitas: Orkla India IPO Lockup - Shares Have Traded Below IPO Price but PE Owner Well in The Money

Orkla India raised about US$190m in its India IPO in Nov 2025. The lockup on its promoter and pre-IPO investors is set to expire soon.

Logo
202 Views
Share
x